New data from the Tsepamo study in Botswana has shown that the prevalence of neural tube defects in women on dolutegravir-based regimens appears to have stabilised at 0.2%.
The NDoH is now recommending dexamethasone (or equivalent) for patients with severe COVID-19 disease requiring respiratory support in the form of ventilation or supplemental oxygen.
The MIC has had a number of enquiries from pharmacists receiving prescriptions for chloroquine for prophylaxis against COVID-19 in healthy people. This is not recommended.
We are excited to tell you that we have great new posters (based on the national and Western Cape 2019 guidelines) available for download – free – from our website.